Despite the consistent reports on the involvement of either ETV1 or ETV4 in invasion and AIG in vitro, and comparing to what is accepted for other tumor types [42, 52], validation of the contribution of these PEA3 members to an increased aggressiveness of prostate tumors is only emerging. The gene discussed is ETV4; the disease is neoplasm.